Dexcom, Inc.
$35.58B- Market cap
- $33.18B
- Debt
- +$3.32B
- Cash
- −$917.70M
Capital structure 91% equity / 9% debt · EV / Revenue 7.63x · EV / EBITDA 26.75x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $33.18B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2019 · Mkt cap
Decision snapshot: DXCM stock price vs EQR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EQR's multiple
Needs EQR P/E.
Implied fair value · at DXCM's multiple
Needs EPS (TTM), DXCM P/E.
Snapshot Sep 3, 8:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DXCM FY 2025 (ended Dec 31, 2025) · EQR FY 2019 (ended Dec 31, 2019). Fiscal years are not aligned.
Trendline
14 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 91% equity / 9% debt · EV / Revenue 7.63x · EV / EBITDA 26.75x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DEXCOM, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Vivmark Residential · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.21x
—
Net debt / EBITDA
Leverage against operating earnings
1.81x
—
Cash and equivalents
Liquid reserves on the balance sheet
$917.70M
—
Total debt
Interest-bearing obligations outstanding
$3.32B
—
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABBOTT LABORATORIES
DXCM vs ABT
Medtronic plc
DXCM vs MDT
BECTON DICKINSON & CO
DXCM vs BDX
AVALONBAY COMMUNITIES INC
DXCM vs AVB
UDR, Inc.
DXCM vs UDR
MID AMERICA APARTMENT COMMUNITIES INC.
DXCM vs MAA
CAMDEN PROPERTY TRUST
DXCM vs CPT
APARTMENT INVESTMENT & MANAGEMENT CO
DXCM vs AIV
ESSEX PROPERTY TRUST, INC.
DXCM vs ESS
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.